Post Conference Highlights: Peptides & Complex Generics Symposium 2025

Day 1 BreakdownThe #PCG2025 Symposium commenced on an inspiring note, setting the stage for two days of insightful discussions, collaborations, and knowledge exchange.Opening SessionDr. Ratnesh Jain, Founder & Director, Mumbai Cluster, delivered the inaugural address, sharing his vision of bringing together pharma professionals, R&D experts, CXOs, and academicians to accelerate advancements in…

BySaurabh ChaubeySeptember 29, 2025

EVENTS

Peptides & Complex Generics Symposium | Sep 25-26, 2025 | Mumbai, India

The Mumbai Biocluster, an initiative of the Institute of Chemical Technology (ICT), Mumbai, and operated as a Section-8 non-profit organization, proudly announces the inaugural edition of the Peptides & Complex Generics Symposium (PCG 2025).This landmark gathering, set to take place on 25–26 September 2025 at The Lalit, Mumbai, aims to spotlight India’s growing role…

BySaurabh ChaubeySeptember 3, 2025

NEWS

Merck Signs a ~$493M Deal with Cyprumed to Develop Oral Peptide Therapeutics

Shots:Cyprumed & Merck have entered into a non-exclusive license & option agreement to develop oral formulations of Merck’s peptides, leveraging Cyprumed’s innovative drug delivery tech As per the deal, Merck has secured non-exclusive global rights to Cyprumed’s oral peptide delivery platform for an undisclosed number of targets, with an option to exclusively license it…

ByRidhi RastogiApril 15, 2025

Post Conference Highlights: Peptides & Complex Generics Symposium 2025

Peptides & Complex Generics Symposium | Sep 25-26, 2025 | Mumbai, India

Merck Signs a ~$493M Deal with Cyprumed to Develop Oral Peptide Therapeutics

Contact US

OUR INFORMATION

FOLLOW US